These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 31918676)
1. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry. Wongpraparut N; Siwamogsatham S; Thongsri T; Ngamjanyaporn P; Phrommintikul A; Jirajarus K; Tangcharoen T; Bhumimuang K; Kaewsuwanna P; Krittayaphong R; Pongakasira R; White HD BMC Cardiovasc Disord; 2020 Jan; 20(1):8. PubMed ID: 31918676 [TBL] [Abstract][Full Text] [Related]
2. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514 [TBL] [Abstract][Full Text] [Related]
3. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649 [TBL] [Abstract][Full Text] [Related]
4. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292 [TBL] [Abstract][Full Text] [Related]
5. Patients with high left ventricular filling pressure may be missed applying 2016 echo guidelines: a pilot study. Michaud M; Maurin V; Simon M; Chauvel C; Bogino E; Abergel E Int J Cardiovasc Imaging; 2019 Dec; 35(12):2157-2166. PubMed ID: 31346831 [TBL] [Abstract][Full Text] [Related]
6. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort. Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146 [TBL] [Abstract][Full Text] [Related]
7. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry. Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683 [TBL] [Abstract][Full Text] [Related]
9. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. Maltais S; Schaff HV; Daly RC; Suri RM; Dearani JA; Sundt TM; Enriquez-Sarano M; Topilsky Y; Park SJ J Thorac Cardiovasc Surg; 2011 Nov; 142(5):995-1001. PubMed ID: 21855899 [TBL] [Abstract][Full Text] [Related]
10. Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry. Saito T; Yoshijima N; Hase H; Yashima F; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K Open Heart; 2020 Jul; 7(2):. PubMed ID: 32641381 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tissue Doppler imaging for predicting ventricular arrhythmias and cardiovascular mortality in ischaemic cardiomyopathy. Biering-Sørensen T; Olsen FJ; Storm K; Fritz-Hansen T; Olsen NT; Jøns C; Vinther M; Søgaard P; Risum N Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):722-31. PubMed ID: 27084397 [TBL] [Abstract][Full Text] [Related]
12. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799 [TBL] [Abstract][Full Text] [Related]
13. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345 [TBL] [Abstract][Full Text] [Related]
14. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease. Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935 [TBL] [Abstract][Full Text] [Related]
15. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. Bart BA; Shaw LK; McCants CB; Fortin DF; Lee KL; Califf RM; O'Connor CM J Am Coll Cardiol; 1997 Oct; 30(4):1002-8. PubMed ID: 9316531 [TBL] [Abstract][Full Text] [Related]
16. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed? Franke J; Wolter JS; Meme L; Keppler J; Tschierschke R; Katus HA; Zugck C Clin Res Cardiol; 2013 Jan; 102(1):23-31. PubMed ID: 22760479 [TBL] [Abstract][Full Text] [Related]
17. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry. Khazanie P; Liang L; Curtis LH; Butler J; Eapen ZJ; Heidenreich PA; Bhatt DL; Peterson ED; Yancy CW; Fonarow GC; Hernandez AF Circ Heart Fail; 2016 Feb; 9(2):e002444. PubMed ID: 26867758 [TBL] [Abstract][Full Text] [Related]
18. Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation. Birkemeyer R; Schneider H; Rillig A; Ebeling J; Akin I; Kische S; Paranskaya L; Jung W; Ince H; Nienaber CA BMC Cardiovasc Disord; 2014 Jun; 14():71. PubMed ID: 24893930 [TBL] [Abstract][Full Text] [Related]
19. Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization. Kaandorp TA; Bax JJ; Bleeker SE; Doornbos J; Viergever EP; Poldermans D; van der Wall EE; de Roos A; Lamb HJ J Cardiovasc Magn Reson; 2010 Jan; 12(1):7. PubMed ID: 20105317 [TBL] [Abstract][Full Text] [Related]
20. Testing for Coronary Artery Disease in Older Patients With New-Onset Heart Failure: Findings From Get With The Guidelines-Heart Failure. O'Connor KD; Brophy T; Fonarow GC; Blankstein R; Swaminathan RV; Xu H; Matsouaka RA; Albert NM; Velazquez EJ; Yancy CW; Heidenreich PA; Hernandez AF; DeVore AD Circ Heart Fail; 2020 Apr; 13(4):e006963. PubMed ID: 32207996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]